Greenphire Sees Burgeoning Demand for its Clinical Trial Payment Solutions


Greenphire, the industry leader in global clinical payment technology, today announced unprecedented year over year growth as a result of outstanding demand for its technology solutions from sponsors, CROs, universities, and hospitals looking to automate their payment processes, simplify workflows, strengthen controls and improve business performance.

Greenphire enters 2016 with strong momentum after adding 150 new clients in 2015. The Company’s client partners have expanded to include seven of the top 10 CROs, nine of the top 10 pharmaceutical companies and many leading research Universities and hospitals, including Duke University, University of Pennsylvania and Louisiana State University.

“The depth of our experience and our intense commitment to automating and optimizing the clinical trial payment process have enabled us to create intelligent technology solutions that bring our clients and users unique value. This commitment has allowed us to successfully build long-term strategic partnerships with industry-leading organizations,” said Jim Murphy, CEO of Greenphire.

Greenphire is the only company that is exclusively dedicated to the clinical trial payment process. While other companies provide payment services, Greenphire’s undivided commitment to optimizing global clinical payment processes, with a patented and proven technology, robust product roadmap and expert team, is a key differentiator that has put Greenphire ahead of competitive offerings.

The growing complexity of clinical trial protocols and the industry’s increased focus on accuracy, efficiency and control has fueled rapid sponsor and CRO adoption in eClinicalGPS, Greenphire’s investigator payment platform. The technology’s unique ability to reduce administrative burdens, decrease payment times and deliver valuable financial insights has proven to be the resource optimization solution that sponsors and CROs need.

“From the onset, Greenphire has been an excellent partner: knowledgeable, hands-on and thorough, with the technology to back it up,” said Bruno Gagnon, President, Xenon Clinical Consulting, Inc. “The expert team works with the entire client organization for flawless implementation and ongoing success.”

Additionally, Greenphire’s ClinCard product, built to automate patient reimbursement, has made approximately 3 million clinical payments, totaling nearly $200 million. As the industry’s only patented solution that completely automates patient reimbursements without using personal data, the ClinCard product is also positioned for continued increased adoption.

To support the demand for its technology, Greenphire has expanded its team over the past 12 months, adding nearly 40 new employees around the world, including industry veteran, Jim Murphy, as the new CEO to lead the Company’s global growth and further advance the development of the Company’s industry-leading payment technology solutions.

To learn more about Greenphire’s global clinical trial payment solutions, visit

About Greenphire
Greenphire is the industry’s leading provider of clinical payment technology, designed to change the way research professionals work. We leverage our proprietary workflow automation and advanced web‐based payment technologies to help our clients improve operational efficiency, access clinical financial analytics, reduce costs, mitigate regulatory risks, increase subject retention and compliance, and produce quantifiable results that improve clinical operations and strategic planning. Learn more at